Related Experiment Video

Updated: May 29, 2026

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

Immunogenic but effective: the HIT-fondaparinux brain puzzler

A Greinacher

    Journal of Thrombosis and Haemostasis : JTH
    |September 21, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
    13:34

    Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

    Published on: April 16, 2019

    A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
    09:42

    A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

    Published on: June 4, 2021

    Related Experiment Videos

    Last Updated: May 29, 2026

    Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
    08:37

    Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

    Published on: December 22, 2020

    Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
    13:34

    Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

    Published on: April 16, 2019

    A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
    09:42

    A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

    Published on: June 4, 2021

    Related Concept Videos

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Prevalence and thrombotic risk of PF4-dependent platelet-activating antibodies.

    Journal of thrombosis and haemostasis : JTH·2026

    Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non-cardiac surgery: an observational cohort study.

    Journal of thrombosis and haemostasis : JTH·2018

    Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA.

    Journal of thrombosis and haemostasis : JTH·2018

    An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura.

    Journal of thrombosis and haemostasis : JTH·2017

    Autoimmune heparin-induced thrombocytopenia.

    Journal of thrombosis and haemostasis : JTH·2017

    Platelet transfusion to reverse antiplatelet therapy before decompressive surgery in patients with intracranial haemorrhage.

    Vox sanguinis·2017

    Autosomal dominant thrombocytopenia caused by a heterozygous CYCS variant: a new family and literature review.

    Journal of thrombosis and haemostasis : JTH·2026

    Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with FIX-Fc or N9-GP extended half-life FIX concentrates.

    Journal of thrombosis and haemostasis : JTH·2026

    Multimodal management of refractory gastrointestinal bleeding in myeloma-associated acquired von Willebrand syndrome: a role for emicizumab prophylaxis.

    Journal of thrombosis and haemostasis : JTH·2026

    CHARACTERIZATION OF A SERIES OF PATIENTS WITH GNE-RELATED THROMBOCYTOPENIA: INSIGHTS INTO PATHOGENESIS, DIAGNOSIS, AND TREATMENT.

    Journal of thrombosis and haemostasis : JTH·2026

    Socioeconomic Status and its Association with Venous Thromboembolism During Pregnancy and Postpartum: Results from a Dutch Population-Based Study.

    Journal of thrombosis and haemostasis : JTH·2026

    Laboratory virus test positivity is not associated with increased venous thromboembolism risk among patients presenting with acute respiratory illnesses to U.S. emergency departments.

    Journal of thrombosis and haemostasis : JTH·2026

    Case Report: Intravascular large B-cell lymphoma presenting with cauda equina syndrome: a rare case and diagnostic dilemma.

    Frontiers in medicine·2026

    A human cytokine response atlas to reconstruct underlying gene regulatory networks.

    bioRxiv : the preprint server for biology·2026

    Effect of heparin on immunological heparin-induced thrombocytopenia-IgG chemiluminescence testing.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026

    Increased mast cells in the thymus during acute thymic involution in Japanese Black calves with a poor prognosis.

    Veterinary immunology and immunopathology·2026

    Chronic intestinal pseudo-obstruction secondary to intestinal leiomyositis in a ragdoll cat.

    Frontiers in veterinary science·2026

    Reconstitution of glycan-driven MHC-I recycling reveals calreticulin as mediator between TAPBPR and tapasin.

    The EMBO journal·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us